Histogen Inc reports results for the quarter ended in March - Earnings Summary

Histogen

14/05/2021 02:24

* Histogen Inc  HSTO.OQ  reported a quarterly adjusted loss
of 14 cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 15 cents per
share.
* Revenue was $431.00 thousand​;  analysts expected zero. 
* Histogen Inc's reported EPS for the quarter was a loss of 14
cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Histogen Inc shares had fallen by 26.4% this quarter and
gained 26.3% so far this year.
* The company reported a quarterly loss of $4.27 million.
* Wall Street's median 12-month price target for Histogen Inc is
$5.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 14 at 01:24 a.m. GMT.
​All figures in US dollars